A Randomised, Double Blind, Crossover Euglycaemic Clamp Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog and With EU Approved Humalog in Patients With Type 1 Diabetes Mellitus
Latest Information Update: 03 Oct 2021
Price :
$35 *
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Adocia
- 25 Jan 2021 Results published in the Adocia Media Release
- 27 Nov 2020 Status changed from recruiting to completed.
- 03 Aug 2020 Status changed from planning to recruiting.